TripSitter Clinic Ltd (KETA) AI Stock Analysis

Top Page

TripSitter Clinic Ltd

(CNQX:KETA)

Select Model

Rating:38Underperform

Price Target:CAD 0.06▼(-67.89% Downside)

Action:downgraded

Date:02/15/26

The score is driven primarily by very weak financial performance (near-zero revenue, ongoing losses, negative equity, and continued cash burn), which outweighs any near-term technical oversold signals. Valuation is also unattractive/unclear due to negative earnings and no dividend support.

Positive Factors

Reduced cash burnFree cash flow losses have materially narrowed versus the very large outflows in FY2022–FY2024. A smaller absolute cash burn improves runway and reduces near-term refinancing urgency, increasing the odds management can execute a restructuring or revenue restart over months.

Negative Factors

Revenue collapseRevenue near zero eliminates operating scale and renders gross margins and unit economics non-informative. With minimal sales, fixed costs and selling efforts cannot be absorbed, making sustainable profitability dependent on a material and durable revenue reboot or significant restructuring.

TripSitter Clinic Ltd (KETA) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 1.27M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -19.2
Beta (1Y): -15.81
Revenue Growth: ―
EPS Growth: ―
Country: Canada
Employees: 0
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Care Facilities

TripSitter Clinic Ltd Business Overview & Revenue Model

Company Description

TripSitter Clinic Ltd. operates a consultative virtual clinic and tele-health platform that connects patients to a licensed physician who can evaluate for a prescribed treatment program of low-dose oral ketamine medication in the United States. Its p...

How the Company Makes Money

null

TripSitter Clinic Ltd Financial Statement Overview

Summary

Financials are severely stressed: revenue has fallen to effectively zero in the most recent periods, losses persist, and shareholders’ equity is deeply negative—raising solvency and funding/dilution risk. Cash burn has moderated versus prior years but operating and free cash flow remain negative.

Income Statement

6Very Negative

Balance Sheet

8Very Negative

Cash Flow

12Very Negative

Financial statement breakdown
Breakdown	TTM	Apr 2024	Jan 2024	Jan 2023	Jan 2022	Jan 2021
Income Statement
Total Revenue	0	0	13.97K	488.30K	87.22K	0
Gross Profit	0	0	-4,703	138.71K	-554.60K	0
EBITDA	-10.39K	-9,606	-348.48K	-1.85M	-10.22M	-177.59K
Net Income	-10.39K	-9,606	-304.86K	-1.87M	-26.11M	-179.33K
Balance Sheet
Total Assets	1,012	1,196	2,825	99.27K	1.46M	780.68K
Cash, Cash Equivalents and Short-Term Investments	1,012	1,196	2,825	54.85K	1.30M	772.39K
Total Debt	365.10K	339.62K	273.05K	133.50K	133.50K	17.88K
Total Liabilities	773.00K	748.57K	730.57K	548.82K	197.59K	93.36K
Stockholders Equity	-771.99K	-747.37K	-727.74K	-449.55K	1.26M	687.32K
Cash Flow
Free Cash Flow	-74.82K	-46.52K	-201.59K	-1.39M	-1.76M	-92.97K
Operating Cash Flow	-74.83K	-46.52K	-201.59K	-1.39M	-1.76M	-92.97K
Investing Cash Flow	0	0	0	0	2.30M	0
Financing Cash Flow	80.39K	54.91K	139.54K	136.43K	16.16K	865.37K

TripSitter Clinic Ltd Technical Analysis

Technical Analysis SentimentPositive

Last Price0.19

Price Trends

50DMA0.19Positive

100DMA0.19Negative

200DMA0.16Positive

Market Momentum

MACD0.00Positive

RSI66.46Neutral

STOCH0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:KETA, the sentiment is Positive. The current price of 0.19 is above the 20-day moving average (MA) of 0.19, above the 50-day MA of 0.19, and above the 200-day MA of 0.16, indicating a bullish trend. The MACD of 0.00 indicates Positive momentum. The RSI at 66.46 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:KETA.

TripSitter Clinic Ltd Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:KETA against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:VHI	74Outperform	CAD 494.63M	65.77	2.79%	―	53.79%	29.92%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:AIDR	44Neutral	CAD 44.56M	-1.64	-444.52%	―	415.06%	-54.80%
TSE:CHS	41Neutral	CAD 10.29M	-1.76	64.52%	―	7.63%	-106.03%
TSE:UDOC	41Neutral	CAD 5.18M	-1.59	355.56%	―	614.03%	51.97%
TSE:KETA	38Underperform	CAD 3.31M	-19.19	8.34%	―	―	―

* Healthcare Sector Average

Performance Comparison

TSE:KETA and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:KETA	TripSitter Clinic Ltd	0.19	0.09	90.00%
TSE:VHI	Vitalhub Corp.	7.80	-3.07	-28.24%
TSE:AIDR	Rocket Doctor Ai Inc	0.44	-0.44	-50.00%
TSE:CHS	Comprehensive Healthcare Systems Inc	0.35	-0.27	-42.74%
TSE:UDOC	Unidoc Health Corp.	0.06	-0.13	-68.42%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Feb 14, 2026

TripSitter Clinic Ltd AI Stock Analysis

Top Page